Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Stifel Healthcare Conference.
The fireside chat will take place on Tuesday, November 11, 2025, at 11:20 AM ET.
The fireside chat can be accessed on the Investor Relations page of the Evolus website here . A replay of the webcast will be available 90 days after the date of the presentation.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau ® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse ™ , a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com , and follow us on LinkedIn , X , Instagram or Facebook .
Jeuveau ® and Nuceiva ® , are registered trademarks and Evolysse ™ is a trademark of Evolus, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251028126300/en/
/Broadcom%20Inc%20logo%20on%20building-by%20Poetra_%20RH%20via%20Shutterstock.jpg)
/Nvidia%20logo%20on%20phone%20screen%20with%20stock%20chart%20by%20xalien%20via%20Shutterstock.jpg)
